FilingSEC EDGAR8-K
Kyntra Bio Receives Nasdaq Delisting Notice and Requests Hearing
· SEC accepted
StageOngoing
Filing content
The company received a delisting notice for failing to meet Nasdaq listing rules but has requested a hearing, which stays the delisting process pending a decision.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…